GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (OTCPK:AKUMQ) » Definitions » Change In Receivables

Akumin (Akumin) Change In Receivables : $-5.7 Mil (TTM As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Akumin Change In Receivables?

Akumin's change in receivables for the quarter that ended in Sep. 2023 was $-1.8 Mil. It means Akumin's Accounts Receivable increased by $1.8 Mil from Jun. 2023 to Sep. 2023 .

Akumin's change in receivables for the fiscal year that ended in Dec. 2022 was $14.3 Mil. It means Akumin's Accounts Receivable declined by $14.3 Mil from Dec. 2021 to Dec. 2022 .

Akumin's Accounts Receivable for the quarter that ended in Sep. 2023 was $118.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Akumin's Days Sales Outstanding for the three months ended in Sep. 2023 was 59.66.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Akumin's liquidation value for the three months ended in Sep. 2023 was $-1,560.7 Mil.


Akumin Change In Receivables Historical Data

The historical data trend for Akumin's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akumin Change In Receivables Chart

Akumin Annual Data
Trend Sep15 Sep16 Sep17 Dec18 Dec19 Dec20 Dec21 Dec22
Change In Receivables
Get a 7-Day Free Trial -15.52 0.41 -3.08 12.31 14.33

Akumin Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.47 -1.60 -0.66 -1.67 -1.76

Akumin Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akumin  (OTCPK:AKUMQ) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Akumin's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=118.1/180.624*91
=59.66

2. In Ben Graham's calculation of liquidation value, Akumin's accounts receivable are only considered to be worth 75% of book value:

Akumin's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=31.641-1680.959+0.75 * 118.1+0.5 * 0
=-1,560.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akumin Change In Receivables Related Terms

Thank you for viewing the detailed overview of Akumin's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Akumin (Akumin) Business Description

Traded in Other Exchanges
Address
8300 West Sunrise Boulevard, Plantation, FL, USA, 33322
Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.
Executives
Ronald J. Bienias officer: Chief Restructuring Officer C/O AKUMIN INC.,, 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Stonepeak Gp Investors Holdings Manager Llc 10 percent owner, other: See Remarks 55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Upper Holdings Lp 10 percent owner, other: See Remarks 55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Holdings Lp 10 percent owner, other: See Remarks 55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Krishna Kumar officer: See remarks C/O AKUMIN INC., 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Lawrence Ross Sinclair director 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
R. David Kretschmer officer: See Remarks 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Murray Lee director 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Scw Capital Management, Lp 10 percent owner 3131 TURTLE CREEK BLVD., SUITE 302, DALLAS TX 75219
Trinity Investment Group, Llc 10 percent owner 3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
Robert N. Cathey 10 percent owner 3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
John R. Wagner 10 percent owner 3838 OAK LAWN AVE., SUITE 450, DALLAS TX 75219
Paul Nelis officer: Chief Information Officer 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Haichen Huang director 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Matt Cameron officer: See Remarks 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322

Akumin (Akumin) Headlines